# K922939: Bard Monopty Disposable Core Biopsy Isnt. W/ Cent.

- Pathway: 510(k) (Traditional)
- Applicant: C.R. Bard, Inc.
- Decided: Feb 16, 1993 after 243 days
- Product code: KNW (Instrument, Biopsy)
- Device class: 2
- Regulation: 21 CFR 876.1075
- Recalls of this device: none
- Data: FDA decisions to Oct 25, 2026; recalls to Oct 12, 2026

## Lineage
No predicates in its family tree.
31 later devices descend from it; 3 cite it directly.
0 of 32 devices in its family (counting itself) have a Class I recall.

## Predicates on the family tree (from the FDA summary)
- None. FDA has not posted a summary or statement for it, so its predicates are not known.

## Most influential descendants
- K133948: Bard (R) Monopty (R) Disposable Core Biopsy Instrument, Bard (R) Max-Core (R) Disposable Core Instrument (2014), 27 descendants of its own
- K141552: Achieve Programmable Auomated Biopsy Systems (2014), 11 descendants of its own
- K171953: Bard Mission Disposable Core Biopsy Instrument (2017), 5 descendants of its own
- K160316: SemiCut Semi-automatic Biopsy Needle, Themy Automatic Disposable Biopsy Device, Palium Automatic Reusable Biopsy Device, EasyCut Semi-automatic Biopsy Needle, MDL Biopsy and Coaxial Introducer Needles (2016), 4 descendants of its own
- K192101: Medone Ultra, Medextra (2020), 2 descendants of its own

Source page: https://510kreport.com/device/K922939
Methodology: https://510kreport.com/methodology